Penumbra (PEN) Capital Expenditures (2014 - 2026)
Penumbra (PEN) posted quarterly Capital Expenditures of $13.5 million for Q2 2026, down 13.08% year-over-year from $15.6 million in Q2 2025, and down 0.94% quarter-over-quarter from $13.7 million in Q1 2026.
Penumbra (PEN) Capital Expenditures (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Capital Expenditures for 13 consecutive years, with $13.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Capital Expenditures fell 13.08% year-over-year to $13.5 million; the TTM figure through Jun 2026 stood at $61.9 million (up 55.25% YoY), while the FY2025 annual figure was $63.7 million, up 200.86% from the prior year.
- Capital Expenditures declined to $13.5 million in Q2 2026 per PEN's latest filing, from $13.7 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $18.4 million in Q4 2025 and bottomed at $3.3 million in Q3 2023.
- Historically, Capital Expenditures has averaged $8.1 million across 5 years, with a median of $5.4 million in 2024.
- Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 55.98% — and 2025, when it surged 243.45%.
- Penumbra's Capital Expenditures stood at $3.6 million in 2022, then climbed by 2.33% to $3.6 million in 2023, then surged by 47.35% to $5.4 million in 2024, then jumped by 243.21% to $18.4 million in 2025, then retreated by 26.54% to $13.5 million in 2026.
- Business Quant data shows PEN's Capital Expenditures at $13.5 million in Q2 2026, $13.7 million in Q1 2026, and $18.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn | 13.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.54 Mn |
| Jun 30, 2026 | 13.54 Mn |
| Mar 31, 2026 | 11.78 Mn |
| Mar 31, 2026 | 11.78 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | -27.50 Mn |
| Sep 30, 2025 | -27.50 Mn |
| Jun 30, 2025 | 27.32 Mn |
| Jun 30, 2025 | 27.32 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 5.82 Mn |
| Mar 31, 2024 | 5.82 Mn |